MAIA Biotechnology, Inc.
MAIA
$2.48
$0.145.98%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.25M | -25.94M | -28.08M | -23.72M | -19.77M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.79M | 10.70M | 12.22M | 7.48M | 3.62M |
| Change in Net Operating Assets | -1.24M | -548.00K | 435.90K | 2.95M | 3.09M |
| Cash from Operations | -15.70M | -15.79M | -15.42M | -13.30M | -13.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.97M | 19.66M | 18.97M | 16.41M | 11.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -795.20K | -1.30M | -1.11M | -2.42M | -2.15M |
| Cash from Financing | 18.18M | 18.36M | 17.86M | 13.99M | 9.27M |
| Foreign Exchange rate Adjustments | -21.60K | 18.30K | -1.20K | -5.60K | -100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.45M | 2.59M | 2.43M | 685.10K | -3.80M |